Commentary
FDA draft guidance on compounding animal drugs from bulk drug substances: a commentary
Published on: 7 July 2016
Articles
-
-
Commentary
-
Review
Solid form changes during drug development: good, bad, and ugly case studies
Published on: 25 February 2016
-
Meeting report
Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD
Published on: 27 January 2016
The Erratum to this article has been published in AAPS Open 2016 2:4
-
Editorial
Editorial for an official journal of the American association of pharmaceutical scientists
Published on: 19 November 2015
-
Review
Solid form changes during drug development: good, bad, and ugly case studies
Published on: 25 February 2016
-
Meeting report
Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD
Published on: 27 January 2016
The Erratum to this article has been published in AAPS Open 2016 2:4
-
Editorial
Editorial for an official journal of the American association of pharmaceutical scientists
Published on: 19 November 2015
-
Commentary
-
Commentary
FDA draft guidance on compounding animal drugs from bulk drug substances: a commentary
Published on: 7 July 2016
Editor's quote
"I am delighted and honored to have been selected as the first Editor-in-Chief of AAPS Open, an open-access journal devoted to the rapid publication of quality articles in the pharmaceutical sciences. The journal will be a global forum for the barrier-free publication of reports of original research as well as other significant work that demonstrates applications of scientific concepts and techniques across the entire breadth of the field. Thus, AAPS Open will provide an important outlet for members of AAPS sections and focus groups to publish papers of interest to their communities, as well as for scientists throughout the field."
Christopher M. Riley,
Editor-in-Chief
AAPS Open
Aims and scope
AAPS Open Selfies
Ready to brighten the scientific community with #openaccess?
Think #AAPSOpen when it’s time to submit your research. Tag @AAPSComms on Twitter to share your selfie using the hashtags #BrightSmiles and #BrightMinds. And thank you to those who have already shared with us on our Facebook page: https://www.facebook.com/media/set/?set=a.1171182752893910.1073741854.133899276622268&type=3!
AAPS Open provides a global forum for the rapid and barrier-free publication of reports of original research that demonstrates applications of scientific concepts and techniques across the breadth of the pharmaceutical sciences. Fully peer-reviewed, AAPS Open supports the international community of experts in pharmaceutical sciences by providing a venue for articles that further the understanding of all aspects of the field. A high degree of innovation is not a required element for publication; the journal seeks to publish papers that are technically sound. AAPS Open welcomes reports from experimental or theoretical studies during the normal course of development of a drug candidate, e.g., assay development and validation, formulation, stability, metabolism screening, bioavailability assessment and comparison, food effects studies, manufacturing approaches, and so forth.
Society affiliation
AAPS Open is an official journal of the American Association of Pharmaceutical Scientists.
AAPS Member Discount
AAPS members receive a $300 discount on the article processing charge (APC) and should visit the AAPS Open member discount page (AAPS login required) to get their discount code before submitting to AAPS Open. To join AAPS, visit the AAPS website.
Advertisement